Article Details
Retrieved on: 2025-01-26 14:57:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bridgewater Associates LP now owns 308,632 shares of the biopharmaceutical company's stock valued at $20,401,000 after acquiring an additional 181,504 ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here